Direct and selective pharmacological disruption of the YAP–TEAD interface by IAG933 inhibits Hippo-dependent and RAS–MAPK-altered cancers
Emilie A. Chapeau(Novartis (Switzerland)), Tobias Schmelzle(Novartis (China))
Cited by 128
Related Papers
Cancer lineage-specific regulation of YAP responsive elements revealed through large-scale functional epigenomic screens
|Nature Communications|2023|21